These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7276986)

  • 41. Activity of creatine kinase in sera from healthy women, carriers of Duchenne muscular dystrophy and cord blood, determined by the "European" recommended method with NAC-EDTA activation.
    Moss DW; Whitaker KB; Parmar C; Heckmatt J; Wikowski J; Sewry C; Dubowitz V
    Clin Chim Acta; 1981 Oct; 116(2):209-16. PubMed ID: 6794955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker).
    Zatz M; Shapiro LJ; Campion DS; Kaback MM; Otto PA
    J Neurol Sci; 1980 Jun; 46(3):267-79. PubMed ID: 7381516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy].
    Cordone G; Venzano V; Rossi G; Cavallero G; Minetti C
    Pediatr Med Chir; 1984; 6(6):819-22. PubMed ID: 6545595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma pyruvate kinase and creatine kinase activity in Becker muscular dystrophy.
    Aston JP; Kingston HM; Ramasamy I; Walters EG; Stansbie D
    J Neurol Sci; 1984 Sep; 65(3):307-14. PubMed ID: 6491692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Genetics and clinical types of progressive muscular dystrophy; creatine kinase and myoglobin as biochemical indices of the disease].
    Miyoshi K; Kawai H; Sasaki H; Iwaasa M; Yagita M; Ise H; Kondo A; Hiasa M
    Nihon Rinsho; 1977 Nov; 35(11):3891-6. PubMed ID: 599669
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of age on the detection rate in Duchenne muscular dystrophy.
    Zatz M; Otto PA
    J Neurol Sci; 1980 Sep; 47(3):407-10. PubMed ID: 7420114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discriminant analysis of ribosomal protein synthesis findings in carrier detection of Duchenne muscular dystrophy.
    Ionasescu V; Burmeister L; Hanson J
    Am J Med Genet; 1980; 5(1):5-12. PubMed ID: 7395900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
    Passos MR; Gonzalez CH; Zatz M
    Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Results of blind testing a method to detect carriers of the Duchenne muscular dystrophy gene.
    Monckton G; Zatz M; Mion CS; Marusyk H
    Am J Hum Genet; 1984 Jul; 36(4):926-30. PubMed ID: 6475962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy.
    Thompson MW; Murphy EG; McAlpine PJ
    J Pediatr; 1967 Jul; 71(1):82-93. PubMed ID: 5293863
    [No Abstract]   [Full Text] [Related]  

  • 51. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers.
    Seay AR; Ziter FA; Wu LH; Wu JT
    Neurology; 1978 Oct; 28(10):1047-50. PubMed ID: 570660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radioimmunoassay of serum myoglobin in neuromuscular diseases.
    Askmark H; Osterman PO; Roxin LE; Venge P
    J Neurol Neurosurg Psychiatry; 1981 Jan; 44(1):68-72. PubMed ID: 7205308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum creatine kinase levels in normal females.
    Satapathy RK; Skinner R
    J Med Genet; 1979 Feb; 16(1):49-51. PubMed ID: 469886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Needle muscle biopsy for carrier detection in Duchenne muscular dystrophy. Part 1. Light microscopy--histology, histochemistry and quantitation.
    Maunder-Sewry CA; Dubowitz V
    J Neurol Sci; 1981 Feb; 49(2):305-24. PubMed ID: 6452514
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of Duchenne muscular dystrophy carriers: quantitative echography and creatine kinasemia.
    Schapira G; Laugier P; Rochette J; Berger G; Katz P; Perrin J
    Hum Genet; 1987 Jan; 75(1):19-23. PubMed ID: 3542803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Dilution effect of serum creatine phosphokinase and myoglobin in progressive muscular dystrophy].
    Ohno T; Morikawa I; Suzuki T; Iwasa M; Mouri A
    No To Hattatsu; 1986 Sep; 18(5):418-20. PubMed ID: 3756026
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum pyruvate kinase in different neuromuscular diseases and in carriers of muscular dystrophy.
    Savonitto C; Bonadonna G; Bongiovanni LG; Duso E; De Grandis D
    Ital J Neurol Sci; 1983 Dec; 4(4):417-22. PubMed ID: 6674240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of carrier status in Duchenne dystrophy by creatine kinase measurement.
    Gruemer HD; Miller WG; Chinchilli VM; Leshner RT; Blasco PA; Hassler CR; Nance WE
    Am J Clin Pathol; 1985 Nov; 84(5):655-8. PubMed ID: 4061390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myoglobin, creatine kinase and creatine kinase subunit-beta in serum from patients and relatives with hypokaliaemic familial periodic paralysis.
    Wiggers P; Nørregaard-Hansen K
    Acta Neurol Scand; 1985 Jan; 71(1):69-72. PubMed ID: 3976355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Duchenne carriers: lactate dehydrogenase isoenzyme 5 in serum and muscle.
    Somer H; Willner J; DeCresce RP; Willner J; Somer M
    Neurology; 1980 Feb; 30(2):206-9. PubMed ID: 7188804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.